MOMO'S BREAKOUT BOARD

[trding]

$CYDY, first drug approval in combo indication early 2020. First cancer patient injected this week.

Listen to the first 60 seconds to Charlie Sheen, in this 2016 interview, talk about the difference between Pro 140 (Leronlimab) after switching from standard Highly Active Antiretroviral Therapy (HAART)

CEO on YahooFinance last month talking about FDA approval.

Highlight: @CytoDyn CEO Nader Pourhassan on his company’s new HIV treatment: pic.twitter.com/enr97s9rSQ

— Yahoo Finance (@YahooFinance) July 12, 2019